Filing Details

Accession Number:
0001384101-18-000064
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-24 18:14:54
Reporting Period:
2018-07-24
Accepted Time:
2018-07-24 18:14:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1384101 Veracyte Inc. VCYT Services-Medical Laboratories (8071) 205455398
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1449535 M Christopher Hall 6000 Shoreline Court
Suite 300
South San Francisco CA 94080
President And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-24 10,000 $0.80 42,455 No 4 M Direct
Common Stock Disposition 2018-07-24 10,000 $11.00 32,455 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-07-24 10,000 $0.00 10,000 $0.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-03-30 No 4 M Direct
Footnotes
  1. The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018.
  2. The option becomes exercisable as to 25% of the shares on March 15, 2011, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.